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Abstract 
 
Biotechnology plays an essential role in the modern industry and in 
guaranteeing sustainable future for humankind. Advances of metabolic 
engineering and systems biology allow the adaption of complex cellular networks 
for the production or uptake of certain molecules, with great economical interest, 
enabling the creation of cell factories. Among the potential microorganisms that 
fit this role is the well-known group, due to their role in food fermentation and, in 
particular, their use in dairy industry, known as Lactic acid bacteria (LAB). Their 
metabolism is known for its relative simplicity and lack of biosynthesis capacity, 
creating a potential application as a cell factory in transformation processes. 
The purpose of this work is to develop through evolutionary engineering a 
strain of LAB capable of utilizing mannitol as the sole carbon source and identify 
mutations in the evolved strain, with the objective of associate these mutations 
with the mannitol consuming phenotype. 
Through the usage of adaptive laboratory evolution (ALE), several strains 
of LAB were evolved and a selected evolved strain of Lactococcus lactis subsp 
cremoris, capable of consuming mannitol as the sole carbon source successfully, 
was sequenced using next-generation sequencing. 
 From the analysis of this genomic data using several bioinformatics tools 
available, 3 mutations affecting the genes pta, adhA and mtlF were identified as 
likely having an impact in the new phenotype presented by the evolved strain. 
This work provides an initial inquiry into a potential application of brown 
algae, which accumulate mannitol, as a new feedstock for biofuel production 
using LAB as cell factories. 
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Resumo 
 
A Biotecnologia tem assumido um papel preponderante nos processos 
industriais da atualidade, tendo em vista a conjugação destes com a questão da 
sustentabilidade da espécie humana. Os avanços na engenharia metabólica e 
na biologia de sistemas tem permitido a adaptação das complexas redes 
celulares, com o intuito de produzir ou consumir certos compostos, de forma a 
aumentar o seu valor económico, criando ‘fábricas celulares’. Entre os potenciais 
organismos para este tipo de aplicação encontra-se um grupo bastante 
conhecido devido à sua função na fermentação de certos alimentos, 
especialmente lacticínios, denominadas bactérias ácido-lácticas. Estas possuem 
um metabolismo relativamente simples e não apresentam várias capacidades 
biossintécticas, tornando-as em potenciais candidatas a serem usadas como 
‘fábricas celulares’ em processos de transformação. 
Neste trabalho pretende-se adaptar através de engenharia evolutiva 
várias espécies de bactérias ácido-lácticas à utilização de manitol como fonte de 
carbono e proceder à identificação de mutações no genoma das estirpes 
evoluídas através de tecnologias de sequenciação de ADN, com o propósito de 
relacionar estas mutações com o fenótipo capaz de consumir manitol. 
Com recurso à engenharia evolutiva, várias estirpes de bactérias ácido-
lácticas foram evoluídas e uma dessas estirpes, Lactococcus lactis subsp 
cremoris, capaz de consumir manitol como a única fonte de carbono, foi 
selecionada para ser sequenciada com recurso tecnologias de sequenciação de 
ADN. 
Através da análise destes dados genómicos usando várias ferramentas 
bioinformáticas, foi possível determinar 3 mutações que afectam os genes pta, 
adhA e mtlF que possivelmente estarão relacionadas com o fenótipo exibido 
pelas espécies evoluídas. 
Este trabalho serve como uma avaliação ao potencial da utilização de 
algas castanhas, que acumulam manitol, como um novo recurso para a produção 
de biocombustíveis, usando bactérias ácido-lácticas como ‘fábricas celulares’ 
para a sua transformação. 
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1. Introduction 
1.1. Motivation and Context 
Industry plays an essential role in the modern society. In the European 
Union alone, “around 1 in 10 (9.8%) of all enterprises in the EU-27’s non-financial 
business economy … were classified to manufacturing (Section C) in 2010, a 
total of 2.1 million enterprises”. Furthermore, “the manufacturing sector employed 
30 million persons in 2010 and generated EUR 1 590 billion of value added”. 1 
However, it had “the highest wastewater production in most countries”2 and it 
accounts for around 20% of the greenhouse gas emissions3 in 2011. It was also 
responsible for the production of “134 million tonnes of chemicals that were 
harmful to the aquatic environment”4 in 2013. This is an issue that must be 
addressed to guarantee a sustainable future for humankind.  
Biotechnology has been one of the pathways followed for solving this 
problem. The use of microorganisms for cleaning-up polluted environments or as 
an alternative to conventional industrial processes, the replacing of fossil fuels for 
biofuels refined from renewable raw materials or waste have a major impact in 
diminishing humanity’s footprint in nature. This area of knowledge is in growing 
demand, as can be confirmed by the inclusion of biotechnology in the Leadership 
in Enabling and Industrial Technologies (LEIT) part of EU’s Horizon 2020 
programme.5 
Microorganisms are an integral part in this new approach to fulfil our needs 
and demands. The concept of a “cell factory” is coming into fruition thanks to the 
                                            
1Manufacturing statistics - NACE Rev. 2 - Statistics Explained. at 
<http://ec.europa.eu/eurostat/statisticsexplained/index.php/Manufacturing_statistics_-
_NACE_Rev._2#> Accessed 29-01-2015 
2Water use in industry - Statistics Explained. at <http://ec.europa.eu/eurostat/statistics-
explained/index.php/Water_use_in_industry#Wastewater_generation_and_discharge> 
Accessed 29-01-2015 
3Greenhouse gas emissions by industries and households - Statistics Explained. at 
<http://ec.europa.eu/eurostat/statistics-
explained/index.php/Greenhouse_gas_emissions_by_industries_and_households#Analysis_by
_economic_activity> Accessed 29-01-2015 
4Chemicals management statistics - Statistics Explained. at 
<http://ec.europa.eu/eurostat/statistics-explained/index.php/Chemicals_management_statistics> 
Accessed 29-01-2015 
5Bio-based Industries - European Commission. at 
<http://ec.europa.eu/programmes/horizon2020/en/area/bio-based-industries> Accessed 29-01-
2015 
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advances of metabolic engineering and systems biology that allow to adapt the 
complex cellular networks for the production or uptake of certain molecules, with 
great economical interest (Tyo, Alper, and Stephanopoulos 2007). There are 
several organisms which were successfully used in this approach or show great 
potential to do so (Nakamura and Whited 2003; S. H. Hong et al. 2004; Jeffries 
and Jin 2004). 
Among them is the well-known group of microorganisms, due to their role 
in food fermentation and, in particular, their use in dairy industry, known as Lactic 
Acid Bacteria (LAB). The name comes from their production of lactic acid as the 
main metabolic end product. LAB are gram-positive bacteria and their 
metabolism rely on carbohydrate fermentation coupled to substrate-level 
phosphorylation. They are a natural inhabitant of plants and human’s and other 
animal’s gastro-intestinal tract, which leads to their classification as generally 
regarded as safe. Notwithstanding their already established use in conserving 
food due to the acidification created by their metabolism, LAB have a special 
interest due to their possible use as cell factories. LAB are already extensively 
used in scientific work, resulting in an abundance of genomes sequenced from 
several species (Douillard and Vos 2014). Furthermore, their metabolism is 
known for its relative simplicity and lack of biosynthesis capacity, requiring 
several amino acids, nucleotide and vitamins for their growth (Kok 1990). LAB 
species include several genera however based on their fermentative nature they 
can generally be classified into two groups: the heterofermenters (Figure 1) and 
the homofermenters (Figure 2), taking in consideration the end-product of 
fermentation. 
The genus Lactobacillus are gram-positive bacteria, facultative anaerobic, 
with an optimum growth temperature between 30º and 40ºC. Their metabolism 
consists of several carbohydrates fermentation pathways, along with substrate-
level phosphorylation and several secondary transport system, which are 
essential for the organism’s survival under stress conditions (Bergey 2009). The 
main fermentation pathways are the Embden-Meyerhof pathway (homolactic 
fermentation) and the pentose phosphate pathway (heterolactic fermentation), 
eventually leading to at least half of the end-product being lactate. In heterolactic 
fermentation, usual end-products include acetate, ethanol, carbon dioxide, 
formate, or succinate (Kandler 1983). 
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Another subgroup of LAB, Lactococcus, shares many traits with the previously 
described Lactobacillus. One of the main differences, beside the difference in cell 
morphology, is their classification as only homofermenters. This genus has a 
great economic significance due to their industrial-scale usage in fermentations 
(Bergey 2009). 
One of the metabolites present in LAB metabolism is mannitol, a six-
carbon sugar alcohol, also synthesized by a diverse group of organisms including 
yeasts, fungi, algae, lichens and several plants where it is commonly used as an 
energy and carbohydrate reservoir (Wisselink et al. 2002; Gaspar 2008). Mannitol 
transport can occur through the phosphotransferase system (PTS) and be further 
metabolized, thus allowing its utilization as a carbon source for the organism. 
Consequently, this leads to new opportunities in the use of organisms that 
assimilate mannitol for biotechnology applications.  Brown algae are a large 
group of multicellular algae that are currently used for the production of mannitol 
from natural products due to its utilization in the food, chemical and 
pharmaceutical industries. Nonetheless, there is a new interest in brown algae 
as a feedstock for biorefinery, due to their high carbon content and availability to 
be mass-cultivated using current farming technologies (Jung et al. 2013). The 
conversion of mannitol to ethanol using brown algae extracts has already been 
accomplished by bacteria and yeast (Horn, Aasen, and Stgaard 2000), creating 
a potential application of brown algae as a new resource for biofuel production, 
using a cell factory in the transformation process.  
1.2. Objectives 
The purpose of this work is to develop through evolutionary engineering a 
strain of LAB capable of utilizing mannitol as the sole carbon source and identify 
mutations in the evolved strain, with the objective of associate these mutations 
with the mannitol consuming phenotype. In order to accomplish this objectives, 
the tasks that need to be achieved fall into four broad categories: 
 Optimization of growth of several LAB strains in defined and complex media. 
 Adapted evolution of selected LAB strains using mannitol as a carbon 
sources. 
 Sequencing of adapted LAB strains. 
 Identification of SNPs, indels that cause adapted/improved phenotype.  
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Figure 1 - Heterofermentative pathway for carbohydrate metabolism in LAB (Gaspar 2008) 
Figure 2 - Homofermentative pathway for carbohydrate metabolism in LAB (Gaspar 2008) 
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1.3. Strains 
Strains evaluated in this thesis are briefly explained below. 
Lactobacillus brevis is obligatory heterofermentative LAB, isolated from 
milk, cheese, sauerkraut, sourdough, silage, cow manure, faeces, mouth, and 
intestinal tract of humans and rats (Bergey 2009). It appears that L. brevis can 
simultaneously consumes numerous carbon sources and due to lack normal 
hierarchical control of carbohydrate utilization (Kim, Shoemaker, and Mills 2009). 
The strain DSM-20054 was isolated from faeces. 6  
Lactobacillus buchneri is obligatory heterofermentative, usually isolated 
from pressed yeast, milk, cheese, fermenting plant material, and human mouth. 
It is identical in almost all characteristics with Lactobacillus brevis (Bergey 2009). 
The strain NRRL B-30929 was isolated from an ethanol production plant (Liu et 
al. 2011) and, consequently, can tolerate high ethanol concentrations (Liu, 
Skinner-Nemec, and Leathers 2008). The strain DSM-20057 was isolated from 
tomato pulp. 7 
Lactobacillus casei is facultative heterofermentative, isolated from milk, 
cheese, and intestinal tract (Bergey 2009). There are reports that L. casei exhibit 
immunomodulatory and anti-tumour effects in vivo (Lee et al. 2004; Dwivedi et al. 
2012). It has been incorporated into food products to confer probiotic properties 
(Dimitrellou et al. 2014). The strain DSM-20011 is L. casei subsp. casei and it 
was isolated from cheese.8 
Lactobacillus coryniformis is facultative heterofermentative, isolated from 
silage, cow dung, dairy barn air, and sewage (Bergey 2009). Two subspecies are 
recognized, subsp coryniformis and subsp torquens. The main difference 
between the two seems to be that subssp coryniformis produces substantial 
amounts of L-(+)-lactic acid while subsp torquens produces exclusively D-(−)-
                                            
6 DSM-20054 at <https://www.dsmz.de/catalogues/details/culture/dsm-20054.html> 
Accessed 15-02-2015  
7 DSM-20057 at <https://www.dsmz.de/catalogues/details/culture/DSM-20057.html> 
Accessed 15-02-2015 
8 DSM-20011 at <https://www.dsmz.de/catalogues/details/culture/dsm-20011.html> 
Accessed 15-02-2015 
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lactic acid. The strain DSM-20001 is L. coryniformis subsp coryniformis and it 
was isolated from silage.9 
Lactobacillus fermentum is obligatory heterofermentative, typically 
isolated from yeast, milk products, sourdough, fermenting plant material, manure, 
sewage, and mouth and faeces of humans (Bergey 2009). The strain DSM 20052 
was isolated from fermented beets.10 
Lactobacillus paracasei is facultative heterofermentative, with two 
subspecies recognized, subsp paracasei and subsp tolerans. The subsp 
paracasei is isolated from dairy products, sewage, silage, humans, and clinical 
sources. The subsp tolerans is isolated only from dairy products and is capable 
of surviving heating at 72°C for 40s (Bergey 2009). The strains in this work, all of 
them subsp paracasei, were DSM-2649, isolated from silage11, DSM20312, 
isolated from the cultured milk drink Yakult12, and DSM-5622. 
Lactobacillus plantarum is facultative heterofermentative, with two 
subspecies, subsp plantarum and subsp argentoratensis. The subsp plantarum 
is isolated from dairy products and environments, silage, sauerkraut, pickled 
vegetables, sourdough, cow dung, and the human mouth, intestinal tract and 
stools, and from sewage. The subsp argentoratensis is isolated from starchy food 
and fermenting food of plant origin (Bergey 2009). L. plantarum has one of the 
largest genomes known among the LAB (Klaenhammer et al. 2002). The strains 
in used in this work are LMG 9211, isolated from human saliva13, and DSM-
20174, isolated from pickled cabbage14. 
Lactococcus lactis is homofermentative, isolated from raw milk, milking 
machines, cheese milk and whey, udders, saliva and skin of cows and bulls, 
grass, soil, and silage. It was three subspecies, subsp lactis, subsp cremoris and 
subsp hordinae (Bergey 2009). It is the first living genetically modified organism 
                                            
9 DSM-20001 at <https://www.dsmz.de/catalogues/details/culture/dsm-20001.html>  
Accessed 15-02-2015 
10 DSM-20052 at < https://www.dsmz.de/catalogues/details/culture/dsm-20052.html> 
Accessed 15-02-2015 
11 DSM-2649 at <https://www.dsmz.de/catalogues/details/culture/dsm-2649.html> 
Accessed 15-02-2015 
12 DSM-20312 at <https://www.dsmz.de/catalogues/details/culture/dsm-20312.html> 
Accessed 15-02-2015 
13 LMG 9211 at <http://bccm.belspo.be/catalogues/lmg-strain-details?NUM=9211> 
Accessed 15-02-2015 
14 DSM 20174 at <https://www.dsmz.de/catalogues/details/culture/dsm-20174.html> 
Accessed 15-02-2015 
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for the treatment of a human disease (Braat et al. 2006). as well as an important 
industrial microorganism used worldwide in food fermentation, especially in the 
manufacture of dairy products. The strain used in this work is MG1363, which 
was derived from another strain originated from cheese starter culture (Gasson 
1983), and a derivation of this strain with a double deletion of the genes ldh and 
ldhB (Δldh ΔldhB) (Gaspar et al. 2011). 
The genus Pediococcus has nine species recognized. They are 
homofermentative. It has been isolated in silage, beer, cheese starter cultures, 
human saliva, digestive tract and faeces (Bergey 2009). The specific strain used 
in this work was isolated from a waste plant. 
 
1.4. Adaptive Laboratory Evolution 
Adaptive laboratory evolution (ALE) is one of the many tools available for 
today’s scientist in this quest for biosustainability. The concept behind ALE dates 
back to the 19th century (Dettman et al. 2012) but its application has been greatly 
expanded in the last decades (Paquin and Adams 1983; Bennett, Dao, and 
Lenski 1990; Elena and Lenski 2003) with different end goals and across 
Figure 3- Illustration of ALE methodology. The possible techniques used in the microorganism growth (a,b), the 
evaluation of fitness along the subsequent generations (c) the analysis of the  genome for detection of modifications that 
can justify the increased fitness exhibited (d) (Dragosits and Mattanovich 2013) 
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numerous species (Jiang et al. 2012; Demeke et al. 2013; K.-K. Hong et al. 2011; 
Kildegaard et al. 2014; Fong et al. 2006; Palsson and Feist 2015). ALE consists 
on exposing a certain microorganism to stress conditions, such as pressure, 
temperature or a certain carbon source, for several generations, leading to 
several phenotypes that will compete in the total population, in order to identify 
what where the changes that made it possible for that microorganism to survive 
and grow under those certain conditions. It mimics the natural process of 
evolution; to which these microorganism are subjected to in their natural 
ecosystems, as opposed to the rational design of new strains, through direct 
genetic modification. In this way, it circumvents one of the main problems with 
rational design, the classification as a genetically modified organism (GMO), 
which carries stricter regulation for application in industries and lower public 
acceptance (Çakar et al. 2012). Moreover, this approach can yield new 
opportunities that are prone to be overlooked through a rational analysis of 
metabolic, regulatory or genome features.  
An ALE experiment (Figure 3) is normally performed for 100 to 2000 
generations, taking between a few weeks to a few months (Dragosits and 
Mattanovich 2013) and it is usually accomplished with two methods, batch 
cultivation in parallel serial cultures or continuous cultures in bioreactors. While 
serial cultures allow for an inexpensive setup and large-scale parallel cultures, it 
leads to fluctuations in growth rate and population density and lacks control over 
the growth environment. Continuous cultures allows a constant growth rate and 
population density as well as a controlled environment and nutrient supply, 
however it comes with a much higher cost. 
The selection of different phenotypes, in nature and in ALE, is associated 
with mutations. The appearance of new technologies such as next generation 
sequencing allowing for whole genome sequencing lead to important insights into 
phenotype-genotype correlation.  
1.5. Next Generation Sequencing 
Next-generation sequencing (NGS) is a broad term applied to the new 
technologies that allowed the parallelization of the sequencing process leading 
to massive outputs of data but differ vastly in template preparation, sequencing 
and imaging. Unlike the Sanger sequencing method (Sanger and Coulson 1975), 
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which relies on separation by electrophoresis, the NGS methodology ditch this 
step in favour of several cycles of addition of modified fluorescent nucleotides 
and imaging. Using Illumina/Solexa technology, one of the dominating brands in 
the market (Metzker 2010), as an example to illustrate the processes behind 
NGS, we see that it makes use of solid-phase amplification to generate clusters 
of recombinant DNA, with target sequences binding to the flow cell and then being 
clonally amplified by bridge amplification, which will then be used in the 
sequencing. This steps consist in several cycles in which a DNA polymerase will 
incorporate one of the competing terminated fluorescent labelled nucleotides, the 
one which complements the target sequence. After washing the remaining 
modified nucleotides, the identity of the incorporated nucleotide is found by 
imaging the fluorescent signal emitted after being excited by a light source and 
Figure 4 - Sequencing method by Illumina/Solexa technology (Metzker 2010). 
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then occurs a cleavage of the terminating group and fluorescent dye15 (Metzker 
2010). The number of cycles will determine the length of the read. This imaging 
data is analysed by the a software designated base caller that will predict the 
base and assign a base quality, which is an estimation of the probability (P) of 
the predicted base being incorrect (errors could occur during the sequencing 
cycles leading to mixed fluorescent signals being emitted from the clusters). This 
base quality is in Phred quality score (Q) which is defined as 
𝑄 =  −10 𝑙𝑜𝑔10 𝑃 
For example, a quality score of 30 indicates that the chances of this base being 
called incorrectly are 1 in 1000. This two parameters, the base called and its 
quality, are the essential information that generate the reads in a FASTQ format. 
After getting these reads it is possible to align them against a reference 
sequence, leading to the identification of modifications, or even de novo assembly 
of genomes. In the case of alignments against a reference sequence, the tools 
responsible for the alignment usually work using indexing of the reference 
genome, such as the Ferragina–Manzini index (Simpson and Durbin 2010) and 
dynamic programming, for example algorithms based on the Needleman–
Wunsch algorithm (Needleman and Wunsch 1970) and the Smith–Waterman 
(Smith and Waterman 1981). The purpose of indexing is to act as a filter and 
determine potential regions where a match between the reads and the reference 
                                            
15Sequencing Technology | Sequencing by Synthesis. at 
<http://www.illumina.com/technology/next-generation-sequencing/sequencing-technology.html> 
Accessed at 29-01-2015 
Figure 5 – NGS data analysis pipeline (Metzker 2010). 
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genome can occur, while dynamic programming can handle mismatch and gaps 
and allows the specification of penalties for substitutions. In this manner, aligners 
take advantage of the speed of indexing and the versatility of dynamical 
programming, which otherwise would take too much time. As such, it is easy to 
relate the evolution of NGS with the growing interest in the ALE approach through 
the exploitation of their synergy.  
Nevertheless, the new insights obtainable from these technologies were 
made accessible by the accompanying development of bioinformatics tools to 
make sense of the high throughput data generated by the NGS. While there is a 
large variety of tools and frameworks available (McKenna et al. 2010; Goecks, 
Nekrutenko, and Taylor 2010), the basic pipeline for NGS data (Metzker 2010) in 
an experiment involving ALE is somewhat similar across them. Normally, it starts 
with a reference sequence from the unevolved strain to which the short sequence 
reads are mapped (read mapping). This allows the discovery of the query 
sequence of the DNA and, by comparison with the reference sequence, the site 
of sequence variants, such as SNPs (single-nucleotide polymorphism) or indels 
(insertions/deletions) accumulated during the experiment. Finally, it is necessary 
to relate these mutations with the annotations available from databases to infer a 
biological consequence that should explain the acquired fitness by the organism 
throughout the ALE experiment (Dettman et al. 2012). 
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2. Experimental Procedures 
2.1. Bacterial Strains and Media 
Several strains of the species of lactic acid bacteria were selected for this 
work (Table 1). These were grown in temperatures according to the provider’s 
instructions. The strains were incubated in two complex media, de Man-Rogosa-
Sharpe (MRS)(De Man, Rogosa, and Sharpe 1960) and M17 (Terzaghi and 
Sandine 1975), and in a minimal chemically defined medium (CDM) (Gaspar et 
al. 2011). Ingredients used in the composition of each medium are detailed in the 
Appendix in Tables A1 to A9. 
 
Table 1 – Bacterial species and strains used in this work 
Species Strain 
Temperature 
(C) 
Lactobacillus buchneri NRRLB 30929 (A) 37º 
Lactobacillus buchneri DSM-20057 (B) 37º 
Lactobacillus plantarum LMG 9211 (C) 30º 
Lactobacillus plantarum DSM-20174 (D) 30º 
Lactobacillus coryniformis subsp. coryniformis DSM-20001 (E) 30º 
Lactobacillus casei DSM-20011 (F) 30º 
Lactobacillus paracasei subsp. paracasei DSM-2649 (G) 30º 
Lactobacillus paracasei subsp. paracasei DSM-20312 (H) 30º 
Lactobacillus paracasei subsp. paracasei DSM-5622 (I) 30º 
Lactobacillus brevis DSM-20054 (J) 30º 
Lactobacillus fermentum DSM-20052 (K) 37º 
Lactococcus lactis subsp. cremoris MG1363 (L) 30º 
Lactococcus lactis subsp. cremoris Δldh ΔldhB MG1363 (M) 30º 
Pediococcus In-house (N) 37º 
 
2.2. Bromocresol assay 
In other to assess the potential of the several strains chosen, an initial 
screening was performed to test the utilization of mannitol as the carbon source. 
For this all three types of mediums were used, MRS, M17 and CDM, each with 
three conditions; no carbon source, 1% glucose and 1% mannitol. To all 9 
medium prepared were added 5% bromocresol purple (Catalogue Number 
32642, Sigma-Aldrich) stock solution (1g/L). The bacteria were grown in 24 deep 
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well plates of 5mL over 48h. Biomass was evaluated visually while the pH change 
was evaluated by the change of colour due to bromocresol purple. 
2.3. Adaptive Laboratory Evolution 
All strains were incubated overnight, from -80º C freezer samples, in 5 mL 
of MRS medium 1% Glucose. A sample of 1 mL was retrieved from this culture 
and centrifuged at 5 G for 5 min. The pellet was resuspended in 1 mL of CDM 
1% Mannitol from which a culture of 10 mL of CDM 1% Mannitol was started at 
an optical density measured at a wavelength of 600 nm (OD600) of 0.05.  
Three independent populations (triplicates) were created for each species. 
Subsequently, the independent populations were re inoculated into fresh media 
to OD600 0.05 after 24h to 48h, depending on the species. The cultures were 
performed in 15 mL centrifuge tubes. For absorbance measures, a 200 µL sample 
was taken from the culture in the beginning and in the end, transferred to a 96-
well plate and read in a Synergy™ H1 (Biotek) plate reader. The number of 
generations was estimated by calculating how many times the optical density 
doubled until the culture was transferred into fresh medium 
 
2.4. Growth Curves Determination and 
Quantification of Fermentation Products 
Growth was evaluated by measuring OD600 at several time points in a 
period of 72h. All strains were incubated overnight, from -80º C freezer samples, 
in 5 mL of MRS medium 1% Glucose. A sample of 1 mL was retrieved from this 
culture and centrifuged at 5 G for 5 min. The pellet was resuspended in 1 mL of 
CDM 1% Mannitol from which a culture of 10 mL of CDM 1% Mannitol was started 
at an OD600 of 0.05.  
Several samples of 200 µL in regular intervals, used for absorbance 
measures in a Synergy™ H1 (Biotek) plate reader as well as a 500 µL sample at 
every 12h were taken for a period of 72h. These 500 µL sample were centrifuged 
at 17 G for 10 min. From the supernatant, 200 µL was removed and stored at -
20º C for High-performance liquid chromatography (HPLC) analysis. HPLC was 
performed using an Aminex® HPX-87H column (Bio-Rad Laboratories Inc.) at 
30ºC, with 5 mM H2SO4 as the elution buffer and a flow rate of 0.6 mL/min in 
order to quantify mannitol (Retention Time 10min), lactate(RT 12min), formate 
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(RT 14min), acetate (RT 15min), acetoin(RT 17.5min), 2,3-butanediol (RT 19min) 
and ethanol (RT 22min). The growth rate was defined as the slope of the linear 
best-fit line in a plot of ln(OD600) versus time (hours) for the exponential phase of 
growth. The concentrations of the metabolites was determined from the 
chromatograms using Dionex™ Chromeleon™ 7.2 Chromatography Data 
System. 
 
2.5. Sequencing of 16S rRNA gene for 
identification of strains 
In order to detect possible contamination of the several populations, they 
were grown on an MRS agar plate from which a small amount of colony was 
retrieved in order to perform a colony PCR. Primers, targeting conserved regions 
of 16S rRNA (5’-AGAGTTTGATCCTGGCTCAG-3’ and 5’-GGCTGCTGG 
CACGTAGTTAG-3’, ordered from Integrated DNA Technologies, Belgium) were 
used to amplify an approximately 500 base pair region(Balcázar et al. 2007). 
Samples for PCR consisted in Maxima Hot Start PCR Master Mix (Thermo 
Scientific, Figure A1), forward and reverse primers at 10 µM concentration and 
the small amount of colony. The PCR involved an initial denaturation of 10 min at 
95º C; 30 cycles which consisted of a denaturation step of 30s at 95º C, an 
annealing step of 30s at 55º C, followed by an extension step of 1 min at 72º C; 
a final extension at the end of the cycles for 10 min at 72º C. The products were 
run on a 1% agarose gels by electrophoresis and visualized by PAGE GelRed™ 
(Biotium). DNA was extracted from the agarose gel using NucleoSpin® Gel and 
PCR Clean-up (Macherey-Nagel) according to the manufacturer’s instructions 
(Figure A2). The extracted DNA was sent to a third party for sequencing (Eurofins 
Genomics). The resulting sequence was analysed by using NCBI BLAST 
megablast algorithm (Morgulis et al. 2008) for identification and EMBL-EBI 
ClustalOmega (Sievers et al. 2011) for comparison of populations. 
 
2.6. Genomic DNA extraction for sequencing 
For the extraction of genomic DNA, three different kits were assessed, 
namely Wizard® Genomic DNA Purification Kit (Promega), QIAamp DNA Mini Kit 
(Qiagen) and ZR Fungal/Bacterial DNA MiniPrep (Zymo Research), all used 
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according to the manufacturer’s instructions (Figures A3 to A5). ZR 
Fungal/Bacterial DNA MiniPrep was selected and the resulting purified DNA was 
sequenced in-house at the Novo Nordisk Foundation Center for Biosustainability 
using Illumina MiSeq techonology. 
 
2.7. Data Analysis 
For the analysis of the genome sequencing data, three pipelines were 
established, using different tools currently available, in order to avoid bias from a 
specific tool/software. 
Initially, using the Galaxy platform16 (Goecks, Nekrutenko, and Taylor 
2010; Giardine et al. 2005; Blankenberg et al. 2010), quality control was 
performed on the raw sequence data using FastQC (Galaxy Tool Version 0.63) 
17 to access which pre-processing steps were necessary. Due to the dataset 
quality no pre-processing steps were performed. 
In the first pipeline (P1), which also used the Galaxy platform, the reads 
were mapped using BWA’s algorithm BWA-MEM (Galaxy Tool Version 0.1) (Li 
and Durbin 2009; Li 2013) and the reference genome available18 (Wegmann et 
al. 2007). After the introduction of read groups using Picard’s19 method 
AddOrReplaceReadGroups (Galaxy Tool Version 1.126.0), the files were merged 
using Picard’s method MergeSamFiles (Galaxy Tool Version 1.126.0) in order to 
simplify the downstream process. The resulting file was filtered for properly paired 
reads and for read mapping quality (Phred scale) equal or above 20, using 
BAMtools’ (Barnett et al. 2011) method Filter. Duplicates reads were identified 
using Picard’s method MarkDuplicates (Galaxy Tool Version 1.56.0) and the file 
was groomed using Picard’s method CleanSam (Galaxy Tool Version 1.126.0). 
Variant calling was performed using Naïve Variant Caller (Galaxy Tool Version 
0.0.2), with the site of the variant having a minimum number of reads of 20 as 
well as the reads having minimum base quality of 30 and mapping quality of 20 
(Phred scale). This file was filtered for the parameter ‘Allelle Frequency’, which 
                                            
16 Galaxy at <http://usegalaxy.org/> 
17Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput 
Sequence Data. at <http://www.bioinformatics.babraham.ac.uk/projects/fastqc/> 
18Lactococcus lactis subsp. cremoris MG1363, complete genome - Nucleotide - NCBI. at 
<http://www.ncbi.nlm.nih.gov/nuccore/AM406671> 
19Picard Tools - By Broad Institute. at <http://broadinstitute.github.io/picard/> 
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resulted from the previous tool, above 0.05, using the vcflib20 method VCFfilter 
(Galaxy Tool Version 0.0.3).  
In the second pipeline (P2), which also used the Galaxy platform, a 
different mapping tool was used, bowtie2 (Galaxy Tool Version 0.4) (Langmead 
and Salzberg 2012; Langmead et al. 2009) while the rest follows according to the 
described in the first pipeline. 
The third pipeline (P3) was performed offline using several three tools. The 
reads were mapped using BWA’s (Version 0.7.12) (Li and Durbin 2009; Li 2013) 
algorithm BWA-MEM. The resulting SAM file was converted to the BAM format 
and ordered using Picard’s (Version 1.139) method SortSam, following by the 
usage of the method MarkDuplicates from the same tool. The variant discovery 
process used GATK (Version 3.4-46) (McKenna et al. 2010), specifically the 
method HaplotypeCaller for the variant calling, with a emission confidence 
threshold of 20 and a calling confidence threshold of 30, following by the filtering 
of the variants using methods SelectVariants and VariantFiltration accordingly to 
the GATK’s Best Practices (DePristo et al. 2011; Van der Auwera et al. 2013). 
The resulting VCF files from the three pipelines were parsed using 
PyVCF21 (Version 0.6.8) and annotated using SnpEff (Version 4.1) (Cingolani et 
al. 2012). 
Amino acid changes were analysed by comparing the modified amino acid 
sequence using NCBI BLAST algorithm blastp (Altschul et al. 1990) followed by 
the algorithm COBALT (Papadopoulos and Agarwala 2007)to align against 
similar sequences. 
  
                                            
20vcflib at <https://github.com/ekg/vcflib> 
21 PyVCF at <https://pyvcf.readthedocs.org/> 
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3. Results 
3.1. Adaptive Laboratory Evolution 
The initial screening of the strains using the bromocresol assay allowed 
for a rough qualification of the potential media and carbon source to be utilized in 
this work.  
In Table 2 we can see that MRS medium presents the best growth results 
for glucose and mannitol, indicated by drop in the pH, shown with the change of 
colour of the medium to bright yellow, as well as by the amount of biomass 
deposited in the bottom of the wells. However, both MRS and M17 exhibit these 
same indications of bacterial growth even when no carbon source was added, 
contrasting with CDM which presents no change in colour nor deposited biomass. 
M17 medium and CDM indicate the growth of some strains using mannitol and 
glucose, but with much better results when using glucose. The strains 
Lactobacillus brevis (J) and Lactobacillus fermentum (K) were not included in this 
assay as they had to be purchased, while all the other were already available in-
house. 
HPLC was used to determine the carbon source usage and the 
fermentation products produced during growth, in MRS medium and CDM, as 
shown in Figures 6 and 7. It is important to note that, unlike the other HPLC 
results presented in this work, the determination of the concentration from the 
chromatogram was done using only one reference standard instead of the usage 
of a calibration curve. Consequently, data shown is not reliable in quantification 
of the metabolites but allows to identify them.  
In this screening we detected that the growth in the MRS medium leads to 
a much higher consumption of the carbon source, as seen in Figure 6, where 
strains L. plantarum (C, D), L. coryniformis (E), L. paracasei (G, H, I), L lactis Δldh 
ΔldhB (M) and Pediococcus (N) consume all the glucose available, in contrast 
with the levels of glucose present in CDM after 48h. Lactate and acetate appear 
as the major fermentation products MRS medium while acetate production does 
not seem to occur in CDM (this medium already contains acetate in a 
concentration similar to the concentration estimated here). 
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Table 2 – Bromocresol assay. (-) indicates the absence of colour change (pH columns) and the absence of cells in the 
bottom of the wells (Biomass column); (±) indicates an intermediate colour between the original one and the bright yellow 
(pH columns) and the presence of small amounts of cells in the bottom of the wells (Biomass column); (+) indicates the 
presence of a bright yellow colour (pH columns) and considerable amount of cells in the bottom of the wells (Biomass 
column). Glu represents glucose and Man represents Mannitol 
Strain MRS MRS + 1% Glu MRS + 1% Man 
 pH Biomass pH Biomass pH Biomass 
A - ± - ± - ± 
B - - ± ± - ± 
C ± ± + + + + 
D ± ± + + + + 
E - ± + ± + + 
F - ± ± + - ± 
G ± + + + + + 
H ± + + + + + 
I ± + + + + + 
L - + + ± + + 
M - + + + + + 
N ± + + + ± ± 
 M17 M17 + 1% Glu M17 + 1% Man 
 pH Biomass pH Biomass pH Biomass 
A - ± - ± - - 
B - - - - - - 
C - ± ± ± - ± 
D - ± ± + - ± 
E - - - - - - 
F - - - - - - 
G - - ± + - - 
H - - - ± - ± 
I - - ± - - - 
L - ± + + ± + 
M - ± + + + + 
N - ± - ± - ± 
 CDM CDM + 1% Glu CDM + 1% Man 
 pH Biomass pH Biomass pH Biomass 
A - - - - - - 
B - - - - - - 
C - - ± ± - ± 
D - - - ± - - 
E - - - - - - 
F - - - - - - 
G - - - - - - 
H - - ± ± - - 
I - - - - - - 
L - - + + - ± 
M - - + ± ± ± 
N - - - ± - - 
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In figure 7, again we see the MRS medium with an higher consumption of 
the carbon source, namely in strains L. plantarum (C, D), L. coryniformis (E), and 
lactate and acetate as the major fermentations products for MRS while no acetate 
productions occurs for CDM. 
When comparing Figure 6 and 7, these results seem to indicate that 
change of carbon source leads to different fermentation products., this can be 
seen in the ethanol production using the MRS medium, where, when using 
glucose, strains L. buchneri (B), L. paracasei (H) and L. lactis Δldh ΔldhB (M) 
produce ethanol while, when using mannitol, it is strains L. plantarum (C, D), L 
coryniformis (E), L. paracasei (G, H, I) and L. lactis (L and M) that produce it. Also 
in the CDM, we can see that, for strain L. lactis Δldh ΔldhB (M), the usage of 
glucose as carbon source leads to the production of lactate, acetoin, 2,3-
butadeniol and ethanol while using mannitol only leads to the production of 
formate and ethanol. 
Growth curves were determined using CDM with 1% mannitol in order to 
select which strains to use in the ALE experiment since there were several strains 
which belonged to the same species.  
In Table 3 we can see that the strain L. lactis Δldh ΔldhB (M) is the best 
performer for both growth rate and maximum OD600. Furthermore, L. coryniformis 
(E), L. paracasei (G) and L. lactis (L) present the higher growth rates but smaller 
maximum OD600 than L. plantarum (C, D) and L. paracasei (I). The L. brevis (J) 
and Pediococcus (N) do not go over 0.150 OD600 which indicates that these cells 
cannot reproduce after the first generation (one doubling of the original 
inoculation of 0.050 OD600) 
The selected strains were L. buchneri (A), L. plantarum (D), L. coryniformis 
(E), L. casei (F), L. paracasei (G), L. fermentum (K), L. lactis (L), L. lactis Δldh 
ΔldhB (M) and Pediococcus (N). 
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Figure 6 - Initial HPLC screening for glucose consumption and fermentation products after 48h. Blank represents 
the medium without addition of cells. Unlike other HPLC results presented in this work that utilize a calibration curve for the 
determination of the concentration of each compound, this concentration was estimated using the relation between the 
area of the peak detected of a single standard concentration (10 g/L for Glucose; 1 g/L for the remaining compounds) in 
the chromatogram and the area detected for the samples. 
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Figure 7 - – Initial HPLC screening for mannitol consumption and fermentation products after 48h. Blank represents 
the medium without addition of cells. Unlike other HPLC results presented in this work that utilize a calibration curve for 
the determination of the concentration of each compound, this concentration was estimated using the relation between 
the area of the peak detected of a single standard concentration (10 g/L for Mannitol; 1 g/L for the remaining compounds) 
in the chromatogram and the area detected for the samples. 
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Table 3 – Growth rate and maximum OD600 after 72h using CDM and mannitol as carbon source. 
Strain Growth rate (h-1) Max OD600 
A 0.05 0.280 
B 0.07 0.274 
C 0.07 0.726 
D 0.07 0.733 
E 0.10 0.352 
F 0.08 0.427 
G 0.11 0.621 
H 0.08 0.499 
I 0.09 0.676 
J 0.08 0.109 
K 0.06 0.389 
L 0.15 0.582 
M 0.25 0.862 
N 0.06 0.143 
 
Table 4 – ALE growth rate evolution. This table presents the average of the three populations of each strain and the 
standard deviation. (-) represents that no data is available as the ALE was stopped. 
Strain Growth rate (h-1) 
 7 days 14 days 21 days 28 days 35 days 42 days 
A 0.12 ± 0.09 0.112 ± 0.005 0.12 ± 0.04 0.11 ± 0.05 - - 
D 0.09 ± 0.01 0.080 ± 0.006 0.09 ± 0.02- - - - 
E 0.149 ± 0.006 0.11 ± 0.03 0.16 ± 0.03 0.15 ± 0.01 - - 
F 0.099 ± 0.008 0.11 ± 0.04 0.11 ± 0.04 0.144 ± 0.005 - - 
G 0.117 ± 0.002 0.10 ± 0.01 0.18 ± 0.03 0.147 ± 0.005 - - 
K 0.10 ± 0.01 0.08 ± 0.01 0.150 ± 0.002 0.12 ± 0.02 - - 
M 0.20 ± 0.02 0.14 ± 0.02 0.165 ± 0.04 0.18 ± 0.02 0.18 ± 0.01 0.21 ± 0.03 
N 0.116 ± 0.001 0.08 ± 0.02 - - - - 
 
Table 5 – ALE maximum OD600 evolution. This table presents the average of the three populations of each strain and 
the standard deviation. (-) represents that no data is available as the ALE protocol was stopped. 
Strain Max OD600 
 7 days 14 days 21 days 28 days 35 days 42 days 
A 0.4 ± 0.2 0.5 ± 0.3 0.45 ± 0.05 0.6 ± 0.1 - - 
D 0.88 ± 0.33 0.88 ± 0.03 0.89 ± 0.02 - - - 
E 0.4 ± 0.2 0.7 ± 0.4 0.77 ± 0.04 0.780 ± 0.003 - - 
F 0.48 ± 0.08 0.78 ± 0.05 0.71 ± 0.01 0.85 ± 0.09 - - 
G 0.75 ± 0.02 0.59 ± 0.04 1.0 ± 0.1 0.87 ± 0.07 - - 
K 0.712 ± 0.004 0.68 ± 0.01 0.58 ± 0.04 0.48 ± 0.02 - - 
M 0.93 ± 0.02 0.82 ± 0.01 0.86 ± 0.08 0.97 ± 0.9 1.04 ± 0.05 1.12 ± 0.05 
N 0.5 ± 0.2 0.3 ± 0.3 - - - - 
 
  
23 
 
Table 6 – Evolution of mannitol consumption during ALE. This table presents the average mannitol concentration 
after 72h of growing of the three populations of each strain and the standard deviation 
Strain Mannitol (g/L) 
 7 days 14 days 
A 6.8 ± 1.7 4.6 ± 3.5 
D 2.17 ± 0.06 1.9 ± 0.2 
E 7 ± 1 5.3 ± 2.3 
F 1.7 ± 0.2 2.3 ± 0.5 
G 6.9 ± 0.7 2.4 ± 0.3 
K 2.61 ± 0.01 2.1 ± 0.1 
M 1.78 ± 0.05 1.37 ± 0.04 
N 6.3 ± 1.8 7.1 ± 2.6 
 
Table 7 – Evolution of fermentation products during ALE. This table presents the average product concentration after 
72h of growing of the three populations of each strain and the standard deviation. (*) represents that it is an average of 
two populations. Absence of standard deviation represents that the value corresponds to only one population. 
Strain Lactate (g/L) Formate (g/L) Acetoin (g/L) Ethanol (g/L) 
 7 days After 14d After 7d After 14d After 7d After 14d After 7d After 14d 
A 2.1 ± 1.2 4.0 ± 4.3 
*0.448 ± 
0.002 
*0.7 ± 0.4 0.18 
*0.09 ± 
0.03 
0.8 ± 0.6 
*1.59 ± 
0.05 
D 8.9 ± 0.1 8.4 ± 0.3 0 0 0 0 0.7 ± 0.2 0.8 ± 0.2 
E 2.3 ± 1.3 1.4 ± 1.1 0 0.9 ± 0.7 0.4 ± 0.2 0.3 ± 0.2 0 *1.3 ± 0.4 
F 3 ± 1 3.9 ± 2.7 0 0.9 ± 0.5 
*0.16 ± 
0.03 
0.4 ± 0.4 0 1.5 ± 0.7 
G 8.0 ± 0.2 
6.60 ± 
0.06 
0.39 ± 
0.05 
0.40 ± 
0.02 
0 0 
0.79 ± 
0.08 
1.00 ± 
0.05 
K 
8.22 ± 
0.08 
8.4 ± 0.2 0 0 0 0 0 
0.65 ± 
0.03 
M 
0.71 ± 
0.05 
0.57 ± 
0.04 
1.70 ± 
0.03 
1.47 ± 
0.02 
1.24 ± 
0.06 
1.12 ± 
0.06 
1.8 ± 0.2 
2.47 ± 
0.05 
N 2.3 ± 1.2 1.9 ± 2.4 *0.6 ± 0.1 0.24 0 0 0.62 0.64 
 
All selected species and strains were put through the ALE protocol. There 
is an improvement of both growth rate and maximum OD600 from the initial strains 
into the first seven days, however no clear trend appears after that.  
In Table 4, L. coryniformis (E), L. paracasei (G) and L. fermentum (K) 
growth rates exhibit an increase after 21 days and a decrease after 28 days. L. 
casei (F) strain only improves its growth rate after 28 days. L. lactis Δldh ΔldhB 
(M) strain never reaches the value measured for the unevolved strain and exhibits 
a decrease after 14 days followed by a positive trend until 42 days. The remaining 
strains present a stable growth rate throughout the evolution.  
In Table 5, we can see that following the improvement after seven days 
there is a decrease in maximum OD600 for strain L. paracasei (G), L. fermentum 
(K) and L. lactis Δldh ΔldhB (M) after 14 days, with K presenting a decreasing 
trend afterwards while M presents a positive trend. L. coryniformis (E) and L. 
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casei (F) improve after 14 days and then maintain this value. The remaining 
strains present a similar maximum OD600 throughout the evolution. 
The strain N was abandoned after 14 days due to poor performance. The 
strain D, while performing well in both mannitol consumption and growth rate 
stopped growing after the third week. Several attempts to restart the culture from 
the last point and earlier samples failed. 
In Table 6, the HPLC data available indicates a clear mannitol 
consumption after seven days with the trend continuing after 14 days with the 
exception of L. casei (F) and Pediococcus (N). 
The data of the end-products fermentation, in Table 7, reveals the 
presence of formate and ethanol in almost all strains, as well as acetoin which 
was not detected in the initial screening (Figure 7). It is also very interesting that 
unlike the other strains, L. plantarum (D) and L. fermentum (K) present a 
homofermentative metabolism, especially L. fermentum (K) which is supposedly 
an obligatory heterofermentative. L. casei (F) exhibits assimilates almost all 
mannitol but does not show the same level of end-products as other strain with 
similar mannitol consumption, particularly after seven days. This, along with the 
average maximum OD600 of 0.48 could be an indication that this strain is 
producing something that it is not being detected by our HPLC analysis. 
It is noteworthy that, as we are analysing three biological replicates, there 
seems to exist differences between them, as can be seen from some high values 
of standard deviation in the growth measurements and HPLC data.  
From the fourth week forward, the samples were identified using 
sequencing of the 16S rRNA gene weekly. At this point, contamination by a 
foreign species was detected in samples from strains L. buchneri (A) and L. 
fermentum (K) and it was also detected contamination by L. lactis subsp. cremoris 
in the samples of strain L. coryniformis (E), L. casei (F) and L. paracasei (G). 
Attempts were made to restart the ALE protocol of these strains but 
contamination by L. lactis subsp cremoris continued to be a problem afterwards. 
The two remaining strains L. lactis subsp cremoris (L and M) continued the 
protocol but after the sixth week, as they did not exhibit noteworthy differences 
between them, only the regular strain of L. lactis subsp cremoris (L) was retained. 
This strain continued with the ALE protocol for a total of 12 weeks which resulted 
in 364 generations.  
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The three populations of L. lactis subsp. cremoris were examined at 
several time points, resulting in the data showed in Figure 8 and Figure 9.  
 In Figure 8 we can see that the growth rate show a positive trend across 
the three populations, with only a slight improvement in Population 3. Mannitol 
consumption seems to improve early on and then remains constant in the last 
generations, with most of it being consumed before 24h from the 58th generation 
onwards. There is an exception in the generation 180th of Population 2 where we 
see a decrease in the consumption before 24h but similar levels at 48h and 72h. 
Figure 8 - Evolutionary trajectory. The growth rates of the evolved population are expressed as points. The 
concentrations of mannitol in the media at different time points are indicated by grey bars. The signal  indicates missing 
data that could not be deduced from the chromatogram 
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Figure 9 displays main fermentation metabolites resulting from the growth 
with mannitol as the carbon source. While Population 3 maintains the same 
metabolic profile throughout all generations, both Population 1 and Population 2 
appear to have some variations in their profile. Population 1 has a reduction in 
lactate production in favour of the others metabolites during the 237th and 301st 
generations. On the other hand, Population 2 appears to favour the production of 
lactate over the other metabolites, when compared with the other two 
populations, with the exception of the 301st generation where there seems to be 
a shift towards acetoin production.  
Another experiment was performed in order to determine the effect in the 
growth of the bacteria at different conditions of temperature (30º C and 37ºC) and 
pH (6.5 and 7.5), as shown in Figure 10. 
In this image we can see that the variation of conditions does not seems 
to affect the growth rate. The variation in pH, which we can be observed 
comparing conditions A (30ºC, pH 6.5) and B (30ºC, pH 7.5), appears to increase 
Figure 9 - Fermentation metabolic profile. Concentration of metabolites at 72h determined by HPLC 
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the absorbance measured at 68h in the original and evolved strains, while also 
increasing at 20h and 41h in the evolved ones. On the other hand, in the evolved 
strains there is a decrease in the absorbance measured at 12h which indicates a 
longer lag phase. The variation in temperature, which can be seen when 
comparing conditions B (30ºC, pH 7.5) and C (37ºC, pH 7.5), seem to affect the 
original strain considerably, with a decrease in absorbance at 41h which indicates 
a much longer lag phase when at 37º C. However, we do not see this effect in 
Population 1 and 2 but we detected a smaller decrease at 12h for Population 3. 
This population seems to have a shorter lag phase than Population 1 and 2, which 
in turn have a shorter lag phase than the original strain, as can be seen by 
comparing the absorbance after 12h between them. 
In order to have a simple understanding if the metabolic profile we 
established was accounting for the metabolized carbon source, in this case 
mannitol, and the respective consequences in the redox status of the cell, we 
calculated a ratio between the carbon in the mannitol metabolized during growth 
Figure 10 –Effects of Temperature and pH variation. The growth rates are expressed as points. The absorbance of 
the media (OD600) at different time points are indicated by grey bars with error bars representing standard deviation (n=3). 
‘Original’ represents the unevolved strain. (A) – Temperature at 30º C and pH of 6.5; (B) – Temperature at 30º C and pH 
of 7.5; (C) – Temperature of 37º C and pH of 7.5.  
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of the cells and the carbon present in the fermentation products (Carbon Balance) 
and a ratio between the NADH consumed in the reactions of the fermentation 
products and the NADH produced from mannitol catabolism (Redox Balance). 
From this we can see that we can account for most of the carbon used by the 
cells, whereas there metabolic route for the catabolism of mannitol leads to an 
imbalance in the NAD+/NADH ratio with an accumulation of NAD+.  
Table 8 – Carbon and Redox Balance. The Carbon balance was calculated as the ratio between the concentration of 
metabolites with carbon after 72h and the initial concentration of mannitol, with the respective balance for number of 
carbon in the metabolite (Carbon Balance). The Redox balance was calculated as the ratio between the concentration 
after 72h  of metabolites that consume NADH in their production reaction and the difference between the final and initial 
concentration of mannitol, with the respective balance for number of NADH/NAD+ involved in the reactions. 
 Original Population 1 Population 2 Population 3 
Carbon Balance (%) 0.88 0.89 0.98 0.95 
Redox Balance (%) 1.07 1.38 1.42 1.42 
 
3.2. Next Generation Sequencing 
In order to establish which mutations had occurred in the evolved strains 
the chromosomal DNA was sequenced and mutations identified. 
Table 9 - Variants detected in all samples (evolved populations and control) and not previously described.  In the 
Effect column first appears three letter code of the amino acid affected followed by its position in the protein sequence. In 
case of a missense mutation, this is followed by the symbol ‘>’ and the three letter code of the substitute amino acid. 
 
 Using the methodology described in section 2.6, we identified 121 
variations. Of these 68 were previously described (Linares, Kok, and Poolman 
2010) in a revision of the original reference genome we used in the analysis, 
which is a strong indication that these 68 variants are in fact errors in the original 
Reference Position 
Reference 
Nucleotide 
Nucleotide 
Change 
Variant Type ORF 
Gene 
Name 
Effect 
295026 T C Missense llmg_0308 rimI2 Ser40>Pro 
430179 T G - - - - 
446867 G A - - - - 
447854 G A Missense llmg_0454 llmg_0454 Ala98>Thr 
487598 T G Stop Gained llmg_0493 llmg_0493 Tyr50 
636585 CA C Frameshift llmg_0642 llmg_0642 Phe101 
732730 T TC Frameshift llmg_0746 malR Ala71 
827811 C T - - - - 
970845 C A Missense llmg_1005 llmg_1005 Ala78>Asp 
1318541 GA G Frameshift llmg_1344 llmg_1344 Arg12 
1817902 C A Missense llmg_1836 xylS Glu463>Asp 
2044751 G A Missense llmg_2061 ftsA Ala37>Val 
2183053 GA G Frameshift llmg_2218 llmg_2218 Ser135 
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sequencing of the genome. Furthermore, 13 were present in all population 
samples and in the control (unevolved strain) sample, which indicates that these 
mutations do not relate with the new phenotype acquired. Lastly, 2 were identified 
in all population samples but were absent in the control sample, as well as one 
that were identified in all samples of a single population (Population 2). The 
remaining 36 variants identified either appear only in some samples of the 
respective population or have a low frequency of occurrence in the reads or only 
appeared in one of the methods used. Thus, these variants were concluded to be 
unreliable and errors derived from our data analysis.  
Of the 13 variants identified in both the population samples and the control, 
we detected 9 SNPs, 5 transitions and 4 transversions, and 4 indels. 
Furthermore, 3 are present in intergenic regions, 8 affect predicted proteins and 
the remaining 2 variants (llmg_1836, llmg_2218) affect proteins inferred from 
homology. From the 10 variants that affect coding regions, 5 were missense, 4 
were frameshifts and 1 was a stop codon gained variants. The variants that affect 
the two proteins inferred from homology are missense variants in the gene xylS 
(llmg_1836), which codes the enzyme alpha-xylosidase, and in the gene ftsA 
(llmg_2061), which codes a protein involved in the cell division. These 13 variants 
could be new undetected sequencing errors in the published genome sequence 
(as the 68 variants that were also detected in this and in previous studies) or they 
could have appeared previously to the beginning of our experiment. 
Table 10 – Variants detected in evolved strains. In the Effect column first appears three letter code of the amino acid 
affected followed by its position in the protein sequence. In case of a missense mutation, this is followed by the symbol 
‘>’ and the three letter code of the substitute amino acid. (*) Only detected in Population 2 samples. 
Reference 
Position 
Reference 
Nucleotide 
Nucleotide 
Change 
Variant 
Type 
ORF 
Gene 
Name 
Effect  
30671* A G Missense llmg_0024 mtlF Glu105>Gly  
752166 G T Missense llmg_0763 pta Gly23>Val  
1978510 A C Missense llmg_1991 adhA Phe186>Val  
 
More importantly, we detected two variants affecting all populations, both 
SNPs and transversions, affecting genes pta (also called eutD) and adhA that 
code, respectively, a phosphotransacetylase and a Zn-dependent alcohol 
dehydrogenase. Furthermore, one SNP, was detected that affect a specific 
population, a transition affecting the gene mtlF that codes a mannitol-specific IIA 
component of a phosphotransferase system (PTS) system for Population 2. 
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4. Discussion and Future Work 
The initial screening with the bromocresol assay allowed for some insights 
about the further development of the experiment. For instance, the ability for both 
MRS and M17 to allow growth even when no carbon source was added to the 
medium could interfere with the ALE experiment due to complexity of their 
ingredients. CDM, which presented no growth when a carbon source was missing 
while allowing growth when the carbon source was present, was identified as the 
suited medium for the rest of the experiment. Furthermore, this assay provided 
some indication that strains selected could use mannitol as a carbon source. Due 
to the poor performance of the M17 medium, the rest of the screening only used 
MRS medium and CDM. 
The HPLC screening and the growth curves determination for the original 
strains supported the decision of using CDM as the growth medium for the ALE 
as well as giving an initial picture of the differences between glucose and mannitol 
metabolism of the strains. 
The mannitol metabolism was further explored with the HPLC analysis of 
the ALE strains and presents some interesting information. Strain K, which is 
Lactobacillus fermentum, presents a homofermentative metabolism when it is 
classified as an obligatory heterofermentative. Strains E and F also seem to shift 
from a homofermentative metabolism in the first week to a heterofermentative in 
the second. This could indicate that the contamination for these two occurred 
earlier. The most likely reason for the contaminations that occurred through the 
ALE protocol seems to be human error in pipetting during the re inoculation step 
done daily. Still, when comparing the values of mannitol consumption from the 
initial screening to the ones determined from the first two weeks of ALE, it 
establishes a clear trend of an increased mannitol consumption. This is also 
corroborated by the increased levels of fermentation products, namely lactate. 
Overall, even if it was not possible to finish the ALE protocol, and therefore the 
genome sequencing, due to the contaminations, it seems likely that these 
approach could yield strains capable of improved mannitol consumption. 
This assumption finds some evidence when looking into the better 
characterized L strain (Figure 6), which shows a clear improvement on mannitol 
consumption between the original strain and the evolved strain at the 58th 
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generation (approximately two weeks) accompanied with the increased levels of 
fermentation products. 
While the L strain used in this work is typically a homofermentative strain 
we can see that from the very beginning (Figure 7) it exhibits a heterofermentative 
metabolic profile, with almost a 2:1:1 ratio of lactate, formate and ethanol, which 
corroborates with a previous study (Neves et al. 2002) where mannitol was used 
as a carbon source. This usage of mannitol leads to the formation of an extra 
NADH molecule that has to be reoxidized downstream, which can explain the 
production of ethanol along with lactate and the absence of perceptible acetate 
production, as ethanol provides an efficient pathway for the recovery of NAD+ 
Furthermore, we also used no aeration during the culture of the cells, which 
should establish a microaerobic environment that has been shown to favour the 
activity of pyruvate formate-lyase over the pyruvate dehydrogenase complex, 
enzymes involved in the conversion of pyruvate to acetyl-CoA (Jensen et al. 
2001). This supports the production of formate due to the activity of pyruvate 
formate-lyase. 
The analysis of the results from the physiological characterization at different 
pH and temperatures indicate that the evolved populations are more tolerant to 
temperature changes with a considerable reduced lag phase when compared 
with the original strain. The increase in growth temperature from 30ºC to 37ºC 
seems to increase lag phase. This effect has been previously described (Chen et 
al. 2015). When considering the variation of pH, we can see that we obtain a 
higher final OD600 when we increase the initial pH to 7,5. This is related to the 
acidification of the growth media due to the metabolic activity. As we did not 
control the pH during the growth process, all cultures had a final pH of 
approximately 4,5 , which likely resulted in growth inhibition  and loss of cell 
viability and the inability to consume all the mannitol present in the medium 
(Hutkins and Nannen 1993; Mercade, Lindley, and Loubière 2000). 
Consequently, starting the culture with a higher pH delays the acidification.  
From the variants detected by our data analysis only 4 seem to be of interest, 
as they appear in our populations but are absent in the control samples. 
Mannitol-specific PTS catalyses the phosphorylation of mannitol alongside 
their translocation across the cell membrane. The IIA domain of the PTS contains 
a permease-specific phosphorylation site which is phosphorylated by phospho-
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HPr and, subsequently, transfers the phosphoryl group to the IIB domain (Saier, 
Hvorup, and Barabote 2005). This role is usually accomplished by a histidine 
such as the one at position 61, which is highly conserved in related proteins 
sequences. The change of glutamate at position 105 for glycine occurs in some 
similar proteins sequences in several Streptococcus strains. 
Phosphotransacetylase is involved in the fermentation of pyruvate to acetate, 
catalysing the conversion of acetyl-CoA and phosphate into acetyl phosphate and 
coenzyme A. This particular change of amino acids at position 23 doesn’t seem 
to occur in similar proteins of different organisms, however a change of glycine 
for alanine is seen in similar protein sequences of several Enterococcus species. 
Furthermore, while glycine and alanine are both small aminoacids, the difference 
in sizes between glycine and valine could have an impact in the protein structure 
and consequently its function. 
The Zn-dependent alcohol dehydrogenase is involved in the fermentation of 
pyruvate to ethanol, catalysing the conversion of acetaldehyde to ethanol using 
NADH. The change of phenylalanine at position 186 to valine occurs in almost all 
sequences of similar proteins with the exception of the strain MG1363, used in 
this work, and strain GE214. This is a good indicator that this SNP shouldn’t affect 
the protein function as a valine in this position is common in Lactococcus lactis 
and several other species. 
It is noteworthy that the 2 variants that appear on all populations affect 
proteins related to the acetate and ethanol production. Acetate does not appear 
in the metabolic profile as it is used in one of the components of the CDM medium 
and it does not change its concentration significantly throughout time. On the 
other hand, ethanol production exhibits a positive trend throughout the evolution. 
While the production of ethanol and the absence of acetate production seem to 
indicate the influence of mannitol as the sole carbon source, as stated before, it 
is possible that these two variants may have positive effect increasing the growth 
of the bacteria using mannitol. 
The variant affecting only Population 2 and the mannitol PTS could explain 
the sudden decrease of mannitol consumption exhibited by this population in the 
180th generation as opposed with the increased trend verified in the other two 
populations.  
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Although the main objective of this work was accomplished, as we have an 
evolved strain capable of using mannitol efficiently, it is also clear that the data 
collect is not enough to determine if the changes in the phenotype of strain L are 
due to the mutations identified here. The introduction of these mutations in the 
original strain through genetic engineering techniques (Holo and Nes 1995) (van 
Pijkeren and Britton 2012) and subsequent physiological characterization would 
verify the importance of these mutations to new phenotype. In the case of a 
positive outcome, the determination of the enzymes activities could contribute to 
the understanding the effects of the mutation in the mannitol catabolism (Even, 
Lindley, and Cocaign-Bousquet 2001). Furthermore, it would also be very 
relevant to do a transcriptional study on the original and evolved strains of both 
pta, adhA and the genes involved in the mannitol PTS (mtlA, mtlD, mtlF and 
mtlR). It would also be interesting to have some other strain from a different 
species to go successfully through the ALE protocol, namely strains D, G and K 
which looked promising. This would allow a cross-species comparison of the 
mechanisms underlying the mannitol consumption and end fermentation 
products. 
Another outlook for future work is the motivation of this work, the potential of 
using brown algae, rich in mannitol, as feedstock for ethanol production. This 
would need a redirection of the metabolism towards ethanol production. The 
obvious path is through the inactivation of the lactate dehydrogenase genes ldhX, 
ldhB, and ldh and the pyruvate formate-lyase genes pfl and pflA. However, this 
could present some troubles as we are removing the shortest way for the 
reoxidation of the extra NADH molecule created with the mannitol consumption. 
Alternatively, a in silico approach using the genome-scale metabolic model 
available (Flahaut et al. 2013) would also be very interesting in order to compare 
the predictions of the model with our actual results. The usage of a chemically 
defined medium during the growth of the bacteria enable us to establish precise 
environmental conditions for the simulations. Additionally, it could also provide 
information about possible strategies for the optimization of ethanol production. 
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5. Conclusion 
Lactic acid bacteria are essential microorganism in industrial context, 
especially in the dairy industry. The simplicity of their metabolic pathways make 
them a prime target for strain engineering coupled with their status as generally 
regarded as safe.  
The main objective of this work was to obtain a strain of lactic acid bacteria 
capable of consuming mannitol as the sole carbon source, looking forward to, in 
the future, create the possibility of using brown algae, rich in mannitol, as a 
feedstock for ethanol production. 
In total, fourteen strains were screened in order to create a selection of 
several species of LAB to put through adaptive laboratory evolution with the 
purpose of selecting for improved growth in mannitol. Nine strains were selected 
and put through ALE protocol. Of these, one was successfully evolved resulting 
in the desired phenotype, as either contamination or poor performance originated 
the stopping of the ALE protocol. 
This evolved strain was then sequenced in order to establish a relation 
between the genotype and the phenotype through possible mutations occurred 
during the ALE. 
Two mutations affecting the enzymes phosphotransacetylase and Zn-
dependent alcohol dehydrogenase, involved in the pathways of acetate and 
ethanol production, respectively, were detected in the evolved strain. 
The main limitations of this work was clearly the number of strains, which 
in a process like adaptive laboratory evolution lead to difficulties with 
contaminations. The daily serial passage of the cells to new media provides a 
huge window of opportunity for human error throughout the experiment. This work 
would be much more robust if we had another strain of LAB from a different 
species of Lactococcus lactis. Another natural limitation was the HPLC time, as 
each sample took 30 minutes to process, which with the biological triplicates for 
each of the 9 strains selected as well as the standards would take over 24h for 
the data acquiring. 
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7. Appendix 
 
Table 11 – Common elements for all media. (*) Used when solid media was needed. The agar was added to the medium 
broth and after thoroughly mixed was autoclaved at 121º C for 20 min. When new plates were need, the solidified medium 
was heated in a microwave and poured into the plates in a laminar flow cabinet. (**) Either one or another was used as 
carbon source, never occurring mixture of both of them. After thoroughly mixed the solution was autoclaved at 121º C for 
20 min. 
Name Provider Catalogue Number Concentration (g/L) 
Agar-Agar* Sigma-Aldrich 05040 7.5 
D-(+)-Glucose** Sigma-Aldrich G7021 10 
D-Mannitol** VWR Chemicals 25313.294 10 
 
Table 12 – MRS broth composition. All ingredients were diluted in deionized water. After thoroughly mixed the solution 
was autoclaved at 121º C for 20 min. The carbon source was added afterwards in a laminar flow cabinet. 
Name Provider Catalogue Number Concentration (g/L) 
Tryptone Enzymatic 
Digest From Casein 
Sigma-Aldrich 95039 10 
Meat Extract Sigma-Aldrich 70164 8 
Yeast Extract Sigma-Aldrich 70161 4 
Sodium Acetate 
Trihydrate 
Sigma-Aldrich S8625 5 
Amonnium Citrate 
Dibasic 
Sigma-Aldrich 09833 2 
Magnesium Sulfate 
Heptahydrate 
Sigma-Aldrich 13142 0.2 
Manganese(II) Sulfate 
Monohydrate 
Sigma-Aldrich M7634 0.05 
Potassium Phosphate 
Dibasic 
Sigma-Aldrich 60353 2 
Tween 80 Sigma-Aldrich P4780 1 
 
Table 13 – M17 medium composition. The M17 broth was diluted in deionized water. After thoroughly mixed the solution 
was autoclaved at 121º C for 20 min. The carbon source was added afterwards in a laminar flow cabinet. 
Name Provider Catalogue Number Concentration (g/L) 
M17 Broth Difco 218561 37.25 
 
Table 14 – Chemically defined broth composition. Each solution was kept individually at 4º C. The solutions were 
mixed in a laminar flow cabinet as well as the carbon source. The medium was then equalized to room temperature before 
adding cells. If agar plates were required, the agar-agar was added to the Basal solution, which could be autoclaved, and 
not the mixture of solutions. 
Name v/v 
Basal solution 87% 
Aminoacid Solution 8% 
Vitamin solution 1% 
Micronutrients solution 1% 
Nitrogenous bases solution 1% 
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Table 15 – Basal solution composition. All ingredients were diluted in deionized water. After thoroughly mixed the pH 
was adjusted to 6.5 and the solution was filtered using a sterile filter with a pore size of 0.2µm. The solution was kept at 
4º C. (*) L-Tyrosine was dissolved in NaOH 2M before addition to the main solution. 
Name Provider Catalogue Number Concentration (g/L) 
β-Glycerol Phosphate 
Disodium 
Sigma-Aldrich 50020 21 
Potassium Phosphate 
Dibasic 
Sigma-Aldrich 60353 1 
Ammonium Citrate 
Dibasic 
Sigma-Aldrich 09833 0.6 
Sodium Acetate 
Trihydrate 
Sigma-Aldrich 32318 1.7 
L-Cysteine 
hydrochloride 
monohydrate 
Merck 102839 0.4 
L-Tyrosine* Sigma Aldrich T8566 0.3 
 
Table 16 – Amino acid solution composition. All ingredients were diluted in deionized water. After thoroughly mixed 
the pH was adjusted to 6.5 and the solution was filtered using a sterile filter with a pore size of 0.2µm. The solution was 
kept at 4º C. 
Name Provider Catalogue Number Concentration (g/L) 
L-Alanine Sigma-Aldrich 055130 3 
L-Arginine Merck 101542 1.55 
L-Asparagine 
Monohydrate 
Sigma-Aldrich A8381 4.4 
L-Aspartic Acid Sigma-Aldrich A9256 5.25 
L-Glutamic Acid 
Potassium Salt 
Monohydrate 
Sigma-Aldrich G1501 6.25 
L-Glutamine Sigma-Aldrich G8540 4.9 
Glycine Sigma-Aldrich G7126 2.2 
L-Histidine 
Monohydrochloride 
Monohydrate 
Sigma-Aldrich H8125 1.9 
L-Isoleucine Sigma-Aldrich I7403 2.65 
L-Leucine Sigma-Aldrich L8000 5.7 
L-Lysine Sigma-Aldrich 62840 5.5 
L-Methionine Sigma-Aldrich M9625 1.55 
L- Phenylalanine Sigma-Aldrich P2126 3.45 
L-Proline Sigma-Aldrich P5607 8.45 
L-Serine Sigma-Aldrich S4500 4.25 
L-Threonine Sigma-Aldrich T8625 2.8 
L-Tryptophan Sigma-Aldrich T0254 0.65 
L-Valine Sigma-Aldrich 94619 4.05 
 
  
41 
 
Table 17 – Vitamin solution composition. All ingredients were diluted in deionized water. After thoroughly mixed the 
pH was adjusted to 6.5 and the solution was filtered using a sterile filter with a pore size of 0.2µm. The solution was kept 
at 4º C and protected from light. (*) D-Biotin and Folic Acid were dissolved in NaOH 2M before addition to the main solution 
(**) Riboflavin was diluted in approximately 150 mL while heating at about 70º C until thoroughly dissolved. 
Name Provider Catalogue Number Concentration (mg/L) 
4-Aminobenzoic Acid Sigma-Aldrich 100536 500 
D-Biotin* Sigma-Aldrich B4639 250 
Folic Acid* Sigma-Aldrich F8758 100 
Nicotinic Acid Sigma-Aldrich 72309 100 
Calcium Panthonate Sigma-Aldrich C8731 100 
Pyridoxamine 
Dihydrochloride 
Sigma-Aldrich P9380 250 
Pyridoxine 
Hydrochloride 
Sigma-Aldrich P6280 200 
Riboflavin** Sigma-Aldrich R9501 100 
Thiamine hydrochloride Sigma-Aldrich T1270 100 
(±)-α-Lipoic acid Sigma-Aldrich T5625 150 
Vitamin B12 Sigma-Aldrich V6629 100 
 
Table 18 – Micronutrients solution. All ingredients were diluted in deionized water. After thoroughly mixed the solution 
was filtered using a sterile filter with a pore size of 0.2µm. The solution was kept at 4º C 
Name Provider Catalogue Number Concentration 
Magnesium Chloride 
Hexahydrate 
Sigma-Aldrich 13152 20 
Calcium Chloride Sigma-Aldrich C8106 5 
Zinc Sulphate 
Heptahydrate 
Sigma-Aldrich 31665 0.5 
 
Table 19 – Nitrogenous bases solution. All ingredients were diluted in NAOH 0.1M. After thoroughly mixed the solution 
was filtered using a sterile filter with a pore size of 0.2µm. The solution was kept at 4º C 
Name Provider Catalogue Number Concentration (g/L) 
Adenine Sigma-Aldrich A8626 1 
Uracil Sigma-Aldrich U0750 1 
Xanthine Sigma-Aldrich X0626 1 
Guanine Sigma-Aldrich G6779 1 
 
Table 20 – HPLC Standards. Each standard was diluted in 5 mM H2SO4 and kept individually at 4º C. 
Name Provider Catalogue Number Concentration (g/L) 
D-(+)-Glucose Sigma-Aldrich 67021 10 
Mannitol puriss p.a. Sigma-Aldrich 33440 10 
Sodium Pyruvate Sigma-Aldrich P2256 10 
Lactic Acid, Kosher  Sigma-Aldrich W261106 10 
Sodium Formate Sigma-Aldrich 71541 10 
Sodium Acetate Sigma-Aldrich S8750 10 
Acetoin Sigma-Aldrich A17951 10 
2,3-Butanediol Acros Organics 107640052 10 
Ethanol Acros Organics 615090010 10 
Glycerol Sigma-Aldrich 49770 10 
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Table 21 – Variants discovered in all samples that were previously described in a revision of the reference 
genome used (Linares, Kok, and Poolman 2010) for the reads mapping. These variants were already identified and 
described in the article mentioned. 
Reference 
Position 
Reference 
Nucleotide 
Nucleotide 
Change 
Variant Type ORF Gene Name Effect 
218269 G GC Frameshift llmg_0227 llmg_0227 Val348fs 
311626 T C Missense llmg_0324 lmrC Cys179>Arg 
549521 C CT - - - - 
589180 G GC - - - - 
594325 T A Missense llmg_0606 recJ Ile263>Lys 
617310 A C Synonymous llmg_0628 llmg_0628 Ser8>Ser 
672541 A T Synonymous llmg_0681 llmg_0681 Leu159>Leu 
672705 T G - - - - 
674846 GA G - - - - 
876869 C G Missense llmg_0910 amtB His82>Asp 
894624 T TG Frameshift llmg_0924 llmg_0924 Lys349 
912618 T A Missense llmg_0944 llmg_0944 Leu46>Gln 
912718 T A Missense llmg_0944 llmg_0944 Asn79>Lys 
977525 AC A Frameshift llmg_1011 lplA Leu393 
1007288 C T Synonymous llmg_1045 bglP Phe230>Phe 
1061785 A T Missense llmg_1101 llmg_1101 Ile36>Asn 
1093299 G GC Frameshift llmg_1127 llmg_1127 Val1327 
1093562 G GC Frameshift llmg_1128 llmg_1128 Val59 
1210278 G GA - - - - 
1277684 T A Missense llmg_1306 llmg_1306 Asn231>Ile 
1492365 T A Synonymous llmg_1518 kinE Leu262>Leu 
1500910 C A Missense llmg_1528 llmg_1528 Asp66>Glu 
1532424 G C Missense llmg_1560 llmg_1560 Pro159>Arg 
1572256 T A - - - - 
1572258 G A - - - - 
1588193 T G Missense llmg_1616 ugd Gln297>Pro 
1588245 T A Missense llmg_1616 ugd Thr280>Ser 
1588246 A T Missense llmg_1616 ugd Asn279>Lys 
1588356 T A Missense llmg_1616 ugd Asn243>Tyr 
1610761 T C Missense llmg_1634 llmg_1634 Ile430>Val 
1614128 G GT Frameshift llmg_1637 mleP Thr384 
1681037 T C Missense llmg_1706 pepV Glu332>Gly 
1731090 T C Synonymous llmg_1749 llmg_1749 Gly335>Gly 
1826407 A G Synonymous llmg_1845 llmg_1845 Tyr12>Tyr 
1826459 A AT - - - - 
1838903 T C Missense llmg_1860 rmaB Thr74>Ala 
1853472 C A Missense llmg_1871 glgP Met85>Ile 
1854998 T A Synonymous llmg_1872 glgA Val95>Val 
1891450 C A Missense llmg_1911 llmg_1911 Trp87>Leu 
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1916378 AT A - - - - 
1921433 GT G Frameshift llmg_1941 llmg_1941 Asn26 
1921460 TC T Frameshift llmg_1941 llmg_1941 Gly17 
1921472 TC T Frameshift llmg_1941 llmg_1941 Gly13 
1921516 C T - - - - 
1921528 GT G - - - - 
1921635 CT C - - - - 
1921650 AT A - - - - 
1921654 AG A - - - - 
1921663 CT C - - - - 
1921673 CA C - - - - 
1921679 AT A - - - - 
1921701 TA T - - - - 
1921706 AT A - - - - 
1921716 AT A - - - - 
1921723 GA G - - - - 
1921742 AT A - - - - 
1921752 GA G - - - - 
1921775 CT C - - - - 
1921787 AG A - - - - 
1933214 G C Synonymous llmg_1951 atpB Gly75>Gly 
1933215 C G Missense llmg_1951 atpB Gly75>Ala 
1935398 CT C - - - - 
1942432 T C Missense llmg_1960 llmg_1960 Ile80>Val 
1942730 C A - - - - 
2112670 C CT - - - - 
2122554 G A Missense llmg_2161 cfa Ser58>Leu 
2122558 C T Missense llmg_2161 cfa Ala57>Thr 
2230257 GA G Frameshift llmg_2272 llmg_2272 Ser587 
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Table 22 – Variants considered unreliable. Variants were deemed unreliable when they did not show in all samples of 
a population or when they did not show in all three pipelines for NGS data analysis. 
Reference 
Position 
Reference 
Nucleotide 
Nucleotide 
Change 
Variant Type 
Gene 
Name 
ORF Effect 
262368 AT A - - - - 
321880 T G Missense llmg_0333 Llmg_033 Ile21>Leu 
643970 T G Missense tnp981 llmg_0647 Thr7>Pro 
670481 T C - - - - 
802833 G GT Frameshift ps339 llmg_0833 Lys50fs 
802835 A G Missense ps339 llmg_0833 Lys50Glu 
802837 A C Missense ps339 llmg_0833 Lys50Asn 
802838 G T Stop Gained ps339 llmg_0833 Glu51 
802841 C T Missense ps339 llmg_0833 Leu52>Phe 
802842 T G Missense ps339 llmg_0833 Leu52>Arg 
802844 T C Stop Loss and Splice site ps339 llmg_0833 Ter53 
845227 A T - - - - 
845229 T A - - - - 
845230 G C - - - - 
845231 A G - - - - 
845232 A T - - - - 
845237 G T - - - - 
945239 G GC - - - - 
1223553 A AAT - - - - 
1223554 AG A - - - - 
1223555 GTGA G - - - - 
1223557 G A - - - - 
1223558 A G - - - - 
1921692 AG A - - - - 
1979137 C A - - - - 
1979138 G A - - - - 
1979141 T A - - - - 
2090422 G T Missense ps435 llmg_2107 Asp14>Glu 
2090423 T A Missense ps435 llmg_2107 Asp14>Val 
2090425 G C Missense ps435 llmg_2107 Asn13>Lys 
2090432 C CG Frameshift ps435 llmg_2107 Arg11 
2090437 T C Synonymous ps435 llmg_2107 Glu9>Glu 
2090439 C G Missense ps435 llmg_2107 Glu9>Gln 
2090441 A C Stop Gained ps435 llmg_2107 Leu8 
2090443 C A Missense ps435 llmg_2107 Lys7>Asn 
2090445 T A Stop Gained ps435 llmg_2107 Lys7 
2522079 G T Missense llmg_2562 llmg_2562 Ala87>Asp 
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Table 23 - Statistics of the variants detected in evolved strains. The samples are name in the format (Pipeline, Population); P1, P2, P3 represent each pipeline; Ctrl represents the original unevolved 
strain; Pop1, Pop2 and Pop3 represent each population; C represent the depth of coverage in that region; F represents the frequency of the variation within those reads. 
Reference 
Position 
P1 Ctrl P2 Ctrl l P3 Ctrl P1 Pop1 P2 Pop1 P3 Pop1 P1 Pop2 P2 Pop2 P3 Pop2 P1 Pop3 P2 Pop3 P3 Pop3 
 C F C F C F C F C F C F C F C F C F C F C F C F 
30671             811 0.88 788 0.88 955 1.00       
752166       614 1.00 602 1.00 651 1.00 703 1.00 686 1.00 727 1.00 793 1.00 778 1.00 853 1.00 
1978510       649 1.00 629 1.00 653 1.00 700 1.00 691 1.00 702 1.00 729 0.93 714 0.92 822 1.00 
 
Table 24 – Statistics of the variants detected in all samples (evolved populations and control) and not previously described. The samples are name in the format (Pipeline, Population); P1, 
P2, P3 represent each pipeline; Ctrl represents the original unevolved strain; Pop1, Pop2 and Pop3 represent each population; C represent the depth of coverage in that region; F represents the 
frequency of the variation within those reads. 
Reference 
Position 
P1 Ctrll P2 Ctrl P3 Ctrl P1 Pop1 P2 Pop1 P3 Pop1 P1 Pop2 P2 Pop2 P3 Pop2 P1 Pop3 P2 Pop3 P3 Pop3 
 C F C F C F C F C F C F C F C F C F C F C F C F 
295026 157 1.00 157 1.00 159 1.00 830 1.00 815 1.00 864 1.00 887 1.00 870 1.00 912 1.00 1001 1.00 980 1.00 1025 1.00 
430179 154 1.00 155 1.00 161 1.00 776 1.00 758 1.00 802 1.00 813 1.00 804 1.00 823 1.00 885 1.00 872 1.00 913 1.00 
446867 152 1.00 152 1.00 153 1.00 760 1.00 743 1.00 767 1.00 869 1.00 855 1.00 884 1.00 999 1.00 981 1.00 1018 1.00 
447854 162 1.00 161 1.00 161 1.00 611 1.00 598 1.00 638 1.00 719 1.00 702 1.00 741 1.00 842 1.00 832 1.00 853 1.00 
487598 132 1.00 132 1.00 136 1.00 603 1.00 591 1.00 616 1.00 719 1.00 701 1.00 741 1.00 825 1.00 810 1.00 844 1.00 
636585 117 0.49 117 0.49 128 1.00 673 0.50 650 0.49 706 1.00 739 0.49 716 0.49 784 1.00 757 0.49 738 0.48 815 1.00 
732730 108 0.50 108 0.50 114 1.00 581 0.49 571 0.50 639 1.00 688 0.50 679 0.50 726 1.00 753 0.49 742 0.49 809 1.00 
827811 138 1.00 138 1.00 141 1.00 726 1.00 707 1.00 737 1.00 771 1.00 756 1.00 779 1.00 837 1.00 822 1.00 843 1.00 
970845 98 1.00 98 1.00 99 1.00 500 1.00 487 1.00 521 1.00 620 1.00 605 1.00 629 1.00 675 1.00 672 1.00 694 1.00 
1318541 103 0.49 105 0.49 112 1.00 489 0.49 478 0.49 512 1.00 530 0.48 524 0.49 571 1.00 592 0.49 588 0.49 639 1.00 
1817902 119 1.00 119 1.00 123 1.00 521 1.00 510 1.00 539 1.00 648 1.00 630 1.00 660 1.00 769 1.00 754 1.00 780 1.00 
2044751 117 1.00 117 1.00 118 1.00 723 1.00 706 1.00 757 1.00 749 1.00 730 1.00 774 1.00 831 1.00 817 1.00 856 1.00 
2183053 154 0.49 158 0.49 166 1.00 754 0.50 748 0.50 780 1.00 865 0.50 849 0.50 900 1.00 962 0.49 947 0.49 1023 1.00 
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Figure 11 - Maxima Hot Start PCR Master Mix (Thermo Scientific) protocol. Full document at < 
https://tools.thermofisher.com/content/sfs/manuals/MAN0012945_Maxima_HotStart_Green_PCR_MasterMix_k1061_U
G.pdf> 
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Figure 12 - NucleoSpin® Gel and PCR Clean-up (Macherey-Nagel) protocol. Full document at < http://www.mn-
net.com/Portals/8/attachments/Redakteure_Bio/Protocols/DNA%20clean-up/UM_PCRcleanup_Gelex_NSGelPCR.pdf> 
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Figure 13 - Wizard® Genomic DNA Purification Kit (Promega) protocol. Full document at < 
https://worldwide.promega.com/~/media/files/resources/protocols/technical%20manuals/0/wizard%20genomic%20dna%
20purification%20kit%20protocol.pdf> 
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Figure 14 - QIAamp DNA Mini Kit (Qiagen) protocol. Full document at < file:///C:/Users/Jos%C3%A9/Downloads/HB-
0329-003-1090246-HB-QIAamp-DNA-Mini-Blood-Mini-0215-WW.pdf> 
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Figure 15 - ZR Fungal/Bacterial DNA MiniPrep (Zymo Research) protocol. Full document at < 
http://www.zymoresearch.com/downloads/dl/file/id/88/d6005i.pdf> 
 
